Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, lawmakers introduced a new federal legalization bill. Idaho cannabis supporters were not able to get an initiative on the ballot. Massachusetts cannabis opponents were able to put repeal on the ballot. And finally, there’s a volunteer opportunity in Vermont.
Continue Reading The Week in Weed: July 24, 2026Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we see a new campaign for legal cannabis in Tennessee. The American Bankers Association sends a letter to Congress. Cannabis advocates in Idaho submitted signatures. And finally, a great comment about the rescheduling hearings.
Continue Reading The Week in Weed: July 10, 2026Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, an old friend reappears, the White House shares its thoughts with Congress, rescheduling hearings start, and finally, there’s info about weed at the New York state fair.
Continue Reading The Week in Weed: July 3, 2026Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we have a look at who’s invited to the DEA’s rescheduling hearings. We note that the Supreme Court has opined on guns and cannabis. There are new regulations as a result of this opinion. And finally, if you want to be a Survivor, you need to leave your weed at home.
Continue Reading The Week in Weed: June 26, 2026Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, the big news is the possibility that Virginia could have a retail market after all! An initiative to make cannabis illegal in Massachusetts takes another step towards appearing on the November ballot. Ohio’s intoxicating hemp ban is facing yet another challenge. And finally, we visit Morocco’s Temple of the Plant.
Continue Reading The Week in Weed: June 19, 2026In late May 2026, the Office of Drug and Alcohol Policy and Compliance and the Office of the General Counsel of the U.S. Department of Transportation (DOT) issued a new Question and Answer (Q&A) addressing how its drug testing regulations apply considering the recent rescheduling of certain marijuana products under federal law. The Q&A provides important clarification for employers with safety-sensitive employees subject to DOT regulations—and reinforces that, despite shifting federal policy, DOT drug testing requirements remain unchanged in key respects.
Continue Reading Legal Update: No Safe Harbor: DOT Rejects State-Licensed Marijuana as Basis to Overturn Positive Drug Test ResultsWelcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we have more news from Virginia. Trulieve lists on Wall Street. Idaho could prohibit cannabis legalization ballot initiatives. And finally, the WNBA now permits its players to use cannabis.
Continue Reading The Week in Weed: June 12, 2026Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, we see lawsuits filed to block cannabis rescheduling. Minnesota is taking steps to overhaul their cannabis industry. Some members of Congress would like guidance on the tax implications of rescheduling. And finally, Ultimate Frisbee has an official THC brand.
Continue Reading The Week in Weed: June 5, 2026In a significant and unprecedented ruling, the New Jersey Appellate Division held in Sanders v. The Levari Group, LLC that job applicants may sue prospective employers under the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (“CREAMMA”). Unless and until the State Supreme Court weighs in, the Sanders decision transforms CREAMMA from a largely regulatory statute into a direct source of civil liability—placing pre-employment drug testing and hiring practices squarely in the litigation crosshairs.
Continue Reading New Jersey Opens the Door to Cannabis Hiring Litigation: Appellate Division Recognizes Private Right of Action Under CREAMMAOn April 22, 2026, the U.S. Department of Justice (DOJ) issued a final order reclassifying certain marijuana-related products under the Controlled Substances Act (CSA). The order places (1) FDA-approved marijuana-derived drug products and (2) marijuana produced and dispensed pursuant to state medical marijuana licensing programs into Schedule III.
At the same time, the DOJ directed the Drug Enforcement Administration (DEA) to conduct a formal administrative hearing, beginning June 29, 2026, to consider whether marijuana more broadly should be rescheduled.
Although this development reflects a meaningful shift in federal policy, it does not legalize marijuana at the federal level. Instead, it introduces a more complex regulatory environment with important—and evolving—implications for employers.
Continue Reading Legal Update: A Dual Framework Emerges: Marijuana’s Schedule III Reclassification and the Road Ahead for Employers